Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Axogen, Inc. (AXGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/18/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/18/2023 8-K Quarterly results
08/11/2023 SC 13G Soleus Capital Master Fund, L.P. reports a 8.2% stake in Axogen, Inc.
08/10/2023 SC 13G/A ArrowMark Colorado Holdings LLC reports a 10.3% stake in Axogen, Inc.
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/07/2023 8-K Quarterly results
Docs: "Axogen, Inc Reports 2023 Second Quarter Financial Results",
"in the Private Securities Litigation Reform Act of 1995. These"
07/24/2023 ARS Form ARS - Annual Report to Security Holders:
07/07/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
06/30/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "136166767.4 AMENDMENT NO. 1 TO THE TERM LOAN AGREEMENT THIS AMENDMENT NO. 1 TO THE TERM LOAN AGREEMENT,"
06/02/2023 144 Form 144 - Report of proposed sale of securities:
06/01/2023 144 Form 144 - Report of proposed sale of securities:
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Quarterly results
Docs: "Axogen, Inc Reports 2023 First Quarter Financial Results"
05/01/2023 8-K Shareholder Nominations Pursuant to Exchange Act Rule 14a-11, Other Events  Interactive Data
05/01/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
03/14/2023 10-K Annual Report for the period ended December 31, 2022
03/14/2023 8-K Investor presentation
Docs: "Axogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Results"
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
02/14/2023 SC 13G/A Point72 Asset Management, L.P. reports a 4.4% stake in Axogen, Inc.
02/03/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/31/2023 SC 13G/A BlackRock Inc. reports a 7.5% stake in AXOGEN, INC
01/10/2023 SC 13G/A ArrowMark Colorado Holdings LLC reports a 8.4% stake in Axogen, Inc.
01/09/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure  Interactive Data
Docs: "Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022 ALACHUA and TAMPA, FL",
"in the Private Securities Litigation Reform Act of 1995. These"
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Investor presentation, Quarterly results
Docs: "Axogen, Inc Reports 2022 Third Quarter Financial Results",
"in the Private Securities Litigation Reform Act of 1995. These"
10/31/2022 8-K Quarterly results
08/25/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "First Amendment to Lease Agreement, by and between Axogen Corporation and Ja-Cole, L.P",
"Eighth Amendment to License and Services Agreement, by and between Axogen Corporation and Community Blood Center (d/b/a Community Tissue Services)"
08/05/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/03/2022 8-K Quarterly results
07/18/2022 8-K Quarterly results
07/11/2022 8-K Quarterly results
06/21/2022 SC 13G Point72 Asset Management, L.P. reports a 5% stake in Axogen, Inc.
05/31/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/26/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy